<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Dis Markers</journal-id><journal-id journal-id-type="iso-abbrev">Dis. Markers</journal-id><journal-id journal-id-type="publisher-id">DM</journal-id><journal-title-group><journal-title>Disease markers</journal-title></journal-title-group><issn pub-type="ppub">0278-0240</issn><issn pub-type="epub">1875-8630</issn><publisher><publisher-name>IOS Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19407360</article-id><article-id pub-id-type="pmc">3833701</article-id><article-id pub-id-type="other">292458</article-id><article-id pub-id-type="doi">10.3233/DMA-2009-0607</article-id><article-categories><subj-group subj-group-type="heading"><subject>Other</subject></subj-group></article-categories><title-group><article-title>Could High Levels of Tissue Polypeptide Specific Antigen, a Marker of Apoptosis Detected in Nonalcoholic Steatohepatitis, Improve after Weight Loss?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tarantino</surname><given-names>Giovanni</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Mazzarella</surname><given-names>Claudia</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Tarantino</surname><given-names>Marianna</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Di Minno</surname><given-names>Matteo Nicola Dario</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Conca</surname><given-names>Paolo</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup><addr-line>Department of Clinical and Experimental Medicine</addr-line><addr-line>Federico II University</addr-line><addr-line>Medical School of Naples</addr-line><country>Italy</country></aff><aff id="I2"><sup>2</sup><addr-line>Department of Biology and Cellular Pathology &#x0201c;L.Califano&#x0201d;</addr-line><addr-line>Federico II University</addr-line><addr-line>Medical School of Naples</addr-line><country>Italy</country></aff><aff id="I3"><sup>3</sup><addr-line>Department of Biomorphological and Functional Sciences</addr-line><addr-line>Federico II University</addr-line><addr-line>Medical School of Naples</addr-line><country>Italy</country></aff><author-notes><corresp id="cor1">*Giovanni Tarantino: <email>tarantin@unina.it</email></corresp></author-notes><pub-date pub-type="ppub"><year>2009</year></pub-date><pub-date pub-type="epub"><day>30</day><month>4</month><year>2009</year></pub-date><volume>26</volume><issue>2</issue><fpage>55</fpage><lpage>63</lpage><history><date date-type="received"><day>21</day><month>4</month><year>2009</year></date><date date-type="accepted"><day>21</day><month>4</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Hindawi Publishing Corporation.</copyright-statement><copyright-year>2009</copyright-year></permissions><abstract><p>Background: Tissue Polypeptide Specific antigen has recently been proposed as diagnostic marker of apoptosis in NonAlcoholic SteatoHepatitis.</p><p>The aim of this study was to validate in patients suffering from NonAlcoholic SteatoHepatitis the clinical utility of this marker after different programs of weight reduction.</p><p>Methods: Overweight/obese patients with visceral adiposity and liver histology compatible were assigned to a Calorically-Restricted diet (<italic>n</italic> = 22), a Calorically-Restricted diet plus EXercise (<italic>n</italic> = 19) or No Healthy Life Style (control group, <italic>n</italic> = 21) for six months. The presence of Body-Weight loss was assessed by a Body Mass Index decrease of at least three points. Serum ALanine aminoTransferase, HOmeostasis Model Assessment method value and Tissue Polypeptide Specific antigen concentrations were determined at time 0, after 3 and 6 months in both the Intervention groups and in the controls&#x02019; one.</p><p>Results: In NonAlcoholic SteatoHepatitis patients who obtained Body-Weight reduction, a significant decrease of the serum Tissue Polypeptide Specific antigen values was showed with a clear linear trend across time, <italic>P</italic> = 0.0001.</p><p>Decrement of Tissue Polypeptide Specific antigen concentrations best differentiated the Body-Weight loss from the body-weight maintenance in respect to Tissue Polypeptide Specific antigen and HOmeostasis Model Assessment method values.</p><p>Conclusion: This study support the clinical utility of serum Tissue Polypeptide Specific antigen antigen levels in the follow-up of overweight/obese patients with NonAlcoholic SteatoHepatitis on weight reduction programs.</p></abstract><kwd-group><kwd>TPS</kwd><kwd>NASH</kwd><kwd>Body-Weight loss</kwd></kwd-group></article-meta></front></article>